Deep MedTech · Spain · Mexico · Global

Nanotechnology
that acts on
human life.

Bionano Research is an applied nanobiotechnology company engineering a new layer of medicine — one that acts beneath the surface of skin, blood and matter. We build tools that intervene before disease begins, that carry the clinical lab into a pocket, and that rewrite what structural materials can do.

3Divisions
5Projects
One commitment
01Who we are

An applied nanobiotech company rebuilding what medicine and materials can do.

Mission. Develop cutting-edge nanotechnology solutions that transform preventive medicine, clinical diagnostics and advanced materials — with direct impact on human quality of life.

Vision. To be the global benchmark in medical nanobiotechnology, leading the transition toward proactive, personalised medicine — and positioning structural nanomaterials as the standard of advanced industry.

I · Biomedical

Biomedical Nanotechnology

Active formulations with nanoparticles that act at the cellular level to protect, repair and optimise the human body.

II · Diagnostics

Cutting-Edge Diagnostics

Ultra-fast analysis platforms that bring the clinical lab to the point of care — in seconds, not hours.

III · Materials

Intelligent Structural Materials

Next-generation nanocomposites with mechanical, thermal and electromagnetic properties impossible with conventional materials.

02The problem we solve

Medicine and materials have reached their ceiling. We break it at the nano scale.

01

Reactive Medicine

Health systems treat symptoms instead of preventing and optimising human biology. We need tools that act before disease appears.

02

Slow, Costly Diagnostics

Current clinical tests take 3–24 hours and depend on expensive hospital infrastructure — delaying decisions that can cost lives.

03

Inflammation & Oxidative Stress

The root of most degenerative diseases. No nanotechnology-grade pharmacological answers exist at wide scale.

04

Materials at Physical Limits

Steel, aluminium and carbon fibre are near their ceiling. Defence, aerospace and automotive require a paradigm shift.

03Portfolio

Three divisions. Five projects.
One commitment to human life.

IDermocosmetics
IIHealth & Diagnostics
IIIAdvanced Materials
Division I · DermocosmeticsNear market
01 / 05

ELI7EK.

ELI7EK device

Next-generation dermal nanoprotector. An active physical and biological barrier built from nanoparticles, hyaluronic acid and amino acids — worn on the skin, working at the cellular level from the first application.

01Extreme UV protection02Antimicrobial shield03Cellular regeneration04Clinically validated
Buy ELI7EK on eli7ek.es
02 — 05Coming Soon
Coming Soon02 / 05

GAMMA.

Division II · Health & Diagnostics

Portable clinical analysis.

GAMMA device
Coming Soon03 / 05

BETA.

Division II · Health

Primary hemorrhage care.

BETA device
Coming Soon04 / 05

DELTA.

Division II · Health

Intravenous biotechnology therapy.

DELTA device
Coming Soon05 / 05

AEGIS·X.

Division III · Advanced Materials

Aerospace nanomaterials family.

AEGIS·X device
04Leadership

A multidisciplinary team spanning science, diplomacy, law and industry.

Francisco N. González Díaz
Financial & Strategic Advisor

Francisco N. González Díaz

Executive and diplomat with 20+ years in international economic promotion. Former Director of ProMéxico and Bancomext, former Ambassador of Mexico to Germany. President of the National Automotive Parts Industry (INA).

Enrique Navarro Isla
Chairman of the Board

Enrique Navarro Isla

Lawyer with a distinguished career in pharmaceutical law. Managing partner of BDCS and former general counsel of Boehringer Mannheim México — drove key biotechnology patent acquisitions in LATAM.

Bernardo Pérez Soltero
Chief Operating Officer

Bernardo Pérez Soltero

Founder and CEO of Deyun Pharma. Leads strategic negotiations with governments, investors and research centres — expanding across Latin America, the United States and the Middle East.

Víctor E. Vázquez Hernández
Chief Technology Officer

Víctor E. Vázquez Hernández

Nanotechnology Engineer with medical specialisation. PhD candidate in Biotechnology, MBA at Universidad Isabel I. Twice awarded 'UdeG Pride'. Winner of the OCI.

Patricia Hernández
Technical & Quality Advisor

Patricia Hernández

Food Chemistry Technician graduated from Universidad de Guadalajara, with extensive experience in quality assurance, development and creation of cosmetic and nutraceutical products.

Patricia G. Vázquez Hernández
Chief Medical Officer

Patricia G. Vázquez Hernández

Medical doctor who graduated at 21. Participant in regenerative medicine projects. Institutional clinical network in Spain and Mexico.

Antonio I. Gómez Tenorio
Legal & Tax Advisor

Antonio I. Gómez Tenorio

Partner at Spanish investment fund Successful Fund (Valencia). Advisor and attorney to leading Mexican businesspeople and corporations. Expert in national and international taxation.

01
07
05Ecosystem

In collaboration with institutions that define international deep tech.

Strategic partners for scientific validation, applied research and global expansion.

MAD eHealth Cluster
Universidad de Guadalajara
CINN · CSIC · U. de Oviedo
SKINLAB P.S.A.
ENISA
EURO-Founding
Universidad Autónoma de Guadalajara
Centro de Investigación Biomedica de Occidente

This network keeps growing. We continue adding strategic allies to extend the reach of our research.

Invitation only · Series round open

Back the transition to proactive medicine.

We're raising alongside strategic partners in deep medtech and advanced materials. Register below and our founding team will reach out with the investor dossier and a confidential data-room invitation.

Confidential. Your information is reviewed by the Bionano Research founding team. We'll reply from investors@bionanoresearch.es